/
Nephros is a commercial-stage company that develops and markets high-performance water filtration solutions for points of use, with a core focus on medical-grade water filtration. Our medical filtration portfolio includes two product lines: infection control and dialysis water.
Operating margin is thin at 6.10%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue up 32.7% YoY with margins expanding 6.1pp.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (TTM)
$19M
▲ +32.7% YoY
Net Income (TTM)
$776K
▲ +1513.5% YoY
Op. Margin
3.54%
▲ +6.1pp YoY
ROIC
5.92%
▲ +10.6pp YoY
Cash Flow & Balance Sheet
FCF
N/A
Op. Cash Flow (TTM)
-$348K
▲ +434.3% YoY
Net Debt
-$3M
Net Cash Position
Cash & Equiv.
$4M
5Y CAGR: +17.0%
Continue Research